As outlined by ACR suggestions, allopurinol is strongly suggested as a first-line urate-reducing medication. Genetic screening is recommended (for the variant identified as HLA B*5801) previous to setting up allopurinol since the carriers of this gene are at an elevated danger of a extreme allergic response.Dos akan dinaikkan secara beransur-ansur